Microemboli from cardiopulmonary bypass are associated with a serum marker of brain injury

Journal of Extra-Corporeal Technology

Volumn 42, Issue 1, 2010, Pages 40-44

  Groom, Robert C ^a   Quinn, Reed D ^a   Lennon, Paul ^a   Welch, Janine ^a,b   Kramer, Robert S ^a   Ross, Cathy S ^b,c   Beaulieu, Peter A ^b,c   Brown, Jeremiah R ^b,c   Malenka, David J ^b,c   O'Connor, Gerald T ^b,c   Likosky, Donald S ^b,c  

^a MAINE MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

Cardiopulmonary bypass; Complications; Coronary artery bypass grafting surgery; Embolism

Indexed keywords

BIOLOGICAL MARKER; PROTEIN S100BETA; UNCLASSIFIED DRUG;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; BRAIN EMBOLISM; BRAIN INJURY; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; FEMALE; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; POSTOPERATIVE PERIOD;

EID: 77950828689     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Stump DA, Kon NA, Rogers AT, Hammon JW. Emboli and neuropsychological outcome following cardiopulmonary bypass. Echocardiography. 1996;13:555-558. (Pubitemid 26337432)
2. Likosky DS, Marrin CA, Caplan LR, et al. Determination of etiologic mechanisms of strokes secondary to coronary artery bypass graft surgery. Stroke. 2003;34:2830-2834.
3. Ali MS, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth. 2000;85:287-298. (Pubitemid 30603976)
4. Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke. 1996;27:1553-1557.
5. Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron- specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke. 1987;18:911-918. (Pubitemid 17126635)
6. Wandschneider W, Thalmann M, Trampitsch E, Ziervogel G, Kobinia G. Off-pump coronary bypass operations significantly reduce S100 release: An indicator for less cerebral damage? Ann Thorac Surg. 2000;70:1577-1579.
7. Svenmarker S, Engstrom KG, Karlsson T, Jansson E, Lindholm R, Aberg T. Influence of pericardial suction blood retransfusion on memory function and release of protein S100B. Perfusion. 2004;19:337-343. (Pubitemid 39642598)
8. Dar MI, Gillott T, Ciulli F, Cooper GJ. Single aortic cross-clamp technique reduces S-100 release after coronary artery surgery. Ann Thorac Surg. 2001;71:794-796. (Pubitemid 32210377)
9. Motallebzadeh R, Kanagasabay R, Bland M, Kaski JC, Jahangiri M. S100 protein and its relation to cerebral microemboli in on-pump and off-pump coronary artery bypass surgery. Eur J Cardiothorac Surg. 2004;25:409-414. (Pubitemid 38340578)
10. Taylor RL, Borger MA, Weisel RD, Fedorko L, Feindel CM. Cerebral microemboli during cardiopulmonary bypass: Increased emboli during perfusionist interventions. Ann Thorac Surg. 1999;68:89-93. (Pubitemid 29338969)
11. Moehring MA, Spencer MP. Power M-mode Doppler (PMD) for observing cerebral blood flow and tracking emboli. Ultrasound Med Biol. 2002;28:49-57.
12. O'Connor GT, Plume SK, Olmstead EM, et al. A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. The Northern New England Cardiovascular Disease Study Group. JAMA. 1991;266:803-809 [see comments].
13. Laursen H, Bodker A, Andersen K, Waaben J, Husum B. Brain oedema and blood-brain barrier permeability in pulsatile and nonpulsatile cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg. 1986;20:161-166. (Pubitemid 16098849)
14. Grocott HP, Croughwell ND, Amory DW, White WD, Kirchner JL, Newman MF. Cerebral emboli and serum S100β during cardiac operations. Ann Thorac Surg. 1998;65:1645-9, discussion 9-50.
15. Stata. Stata Statistical Software: Release 10.0. College Station, TX: Stata Corporation; 2008.
16. Brown WR, Moody DM, Challa VR, Stump DA, Hammon JW. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. Stroke. 2000;31:707-713.
17. Fazio V, Bhudia SK, Marchi N, Aumayr B, Janigro D. Peripheral detection of S100β during cardiothoracic surgery: What are we really measuring? Ann Thorac Surg. 2004;78:46-52; discussion 52-53.
18. Jonsson H, Johnsson P, Birch-Iensen M, Alling C, Westaby S, Blomquist S. S100β as a predictor of size and outcome of stroke after cardiac surgery. Ann Thorac Surg. 2001;71:1433-1437. (Pubitemid 32452520)
19. Jonsson H, Johnsson P, Alling C, Backstrom M, Bergh C, Blomquist S. S100β after coronary artery surgery: Release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg. 1999;68:2202-2208. (Pubitemid 30027850)
20. Snyder-Ramos SA, Gruhlke T, Bauer H, et al. Cerebral and extracerebral release of protein S100β in cardiac surgical patients. Anaesthesia. 2004;59:344-349. (Pubitemid 38489293)
21. Ascione R, Ghosh A, Reeves BC, et al. Retinal and cerebral microembolization during coronary artery bypass surgery: A randomized, controlled trial. Circulation. 2005;112:3833-3838. (Pubitemid 43739480)
22. Jonsson H, Johnsson P, Alling C, Westaby S, Blomquist S. Significance of serum S100 release after coronary artery bypass grafting. Ann Thorac Surg. 1998;65:1639-1644. (Pubitemid 28313622)
23. Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke. 1994;25:1393-1399. (Pubitemid 24198586)
24. Hammon JW, Stump DA, Butterworth JF, et al. Coronary artery bypass grafting with single cross-clamp results in fewer persistent neuropsychological deficits than multiple clamp or off-pump coronary artery bypass grafting. Ann Thorac Surg. 2007;84:1174-8, discussion 1178-1179.
25. Moody DM, Brown WR, Challa VR, Stump DA, Reboussin DM, Legault C. Brain microemboli associated with cardiopulmonary bypass: A histologic and magnetic resonance imaging study. Ann Thorac Surg. 1995;59:1304-1307.
26. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. The Journal of Thoracic and Cardiovascular Surgery 2006;132:283-290.
27. Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ. The cardiotomy trial: A randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation. 2007;116:I89-97. (Pubitemid 47480775)
28. Likosky DS, Leavitt BJ, Marrin CA, et al. Intra- and postoperative predictors of stroke after coronary artery bypass grafting. Ann Thorac Surg. 2003;76:428-434, discussion 35.
29. Likosky DS, Caplan LR, Weintraub RM, et al. Intraoperative and postoperative variables associated with strokes following cardiac surgery. Heart Surg Forum. 2004;7:E271-6.
30. Stump DA, Rogers AT, Hammon JW, Newman SP. Cerebral emboli and cognitive outcome after cardiac surgery. J Cardiothorac Vasc Anesth. 1996;10:113-8, quiz 118-119.
31. Rodriguez RA, Williams KA, Babaev A, Rubens F, Nathan HJ. Effect of perfusionist technique on cerebral embolization during cardiopulmonary bypass. Perfusion. 2005;20: 113-210.
32. Borger MA, Peniston CM, Weisel RD, Vasiliou M, Green RE, Feindel CM. Neuropsychologic impairment after coronary bypass surgery: Effect of gaseous microemboli during perfusionist interventions. J Thorac Cardiovasc Surg. 2001;121:743-749. (Pubitemid 33733598)
33. Groom RC, Quinn RD, Lennon P, et al. Detection and elimination of microemboli related to cardiopulmonary bypass. Circ Cardiovasc Qual Outcomes. 2009;2:191-198.